Future Strategies for Drug Delivery with Particulate Systems (1998)

Nanoparticles and Liposomes for Drug Targeting, E. Fattal, H. Alphandary, C. Weingarten, Ch. Vauthier, C. Dubernet, A. Andremont, and P. Couvreur Design of a New Eye Delivery System for Oligonucleotide Based on a Liposomal Dispersion in a Gel, A. Bochot, E. Fattal, and P. Couvreur Alginate Nanoparticles as a Noval Carrier for Antisense Oligonucleotides, I. Aynie, Ch. Vauthier, E. Fattal, M. Foulquier, and P. Couvreur Splenic Trapping of Nanoparticles: Complementary Approaches for in situ Studies, M. Dimoy, S. Gibaud, J.P. Andreux, C. Weingarten, B. Gouritin, and P. Couvreur Synthesis of a Noval Poly(MePEG-co-alkyl) Cyanoacrylate, Amphiphilic Copolymer for the Preparation of PEG-Coated Nanoparticles, M.T. Peracchia, D. Desmaele, J. d'Angelo, and P. Couvreur Lipid-Based Drug Delivery Systems for Peptide and Protein Drug Delivery, S. Frokjaer, K. Jorgensen, and Ch. Vermehren Fat Emulsions Based on Structured Lipids as Delivery Systems for Intravenous Use, H. Hedeman, H Brondsted, A. Mullertz, and S. Frokjaer Relationship Between Lipid Bilayer Micro-Structure and Functional Properties of Liposomes, K. Jorgensen, M.C. Sabra, J. Risbo, and O.G. Mouritsen Medium-Chain Lecithin in Nasal Drug Delivery Systems: Advantages and Drawbacks, Ch. Vermehren, H.S. Hansen, and M.K. Thomsen Interaction of Plasma Proteins with Liposomes-Influence of Surface Properties on Adsorption Patterns and Protein Conformation, J.E. Diederichs Iron Oxides as Contrast Agents in Magnetic Resonance Lymphography, M. Kresse Solid Lipid Nanoparticles, Nanosuspensions and Liposomes for Pharmaceutical and Cosmetic Applications, R.H. Muller Particulate Systems for the Controlled Delivery of Active Compounds in Pharmaceutics and Cosmetics, R.H. Muller Solid Lipid Nanoparticles (SLN (TM)) for Oral Administration-Drug Incorporation and Degradation, S.A. Runge and R.H. Muller Nanosuspensions-A Noval Forumulation for Poorly Soluble Drugs, K. Peters and R.H. Muller Two-Dimensional Electrophoresis (2-DE) for the Determination of Plasma Proteins Adsorbed on Model Drug Carriers, M. Luck, B.-P. Paulke, W. Schroeder, and R.H. Muller Development of a Liposomal Formulation for Hair Care Use, J. Herbort, J.E. Diederichs, and R.H. Muller Liposomes as Drug Carrier for Diagnostics, Cytostatics and Genetic Material, R. Reszka Preparation and Characterization of a New Generation of Cationic Liposomes for Gene Transfer, D. Groth, C. Lehman, O. Keil, M. Schneider, and R. Reszka Characterization of Gene Transfer Vesicle by Electron Microscopy, C. Lehman, D. Groth, O. Keil, M. Schneider, M. Rudolph, and R. Reszka Strategies for Site Specific, Time and Rate Controlled Delivery of Drugs, Genes and Antigenes, D.J.A. Crommelin, W.E. Hennink, and G. Storm Development of an Optimized Immuno-Enzymosome Formulation for Application in Cancer Therapy, M.J. Fonseca, M.H. Vingerhoeds, H.J. Haisma, D.J.A. Crommelin, and G. Storm Factors Influencing Lymphatic Disposition of Liposomes after Subcutaneous Administration, C. Oussoren and G. Storm MHC II/Peptide Liposomes as Artificial Antigen Presenting Cells, A.J.M.L. van Rensen, L.S. Taams, M.CJ.T. Grosfeld-Stulemeyer, A. Besseling, W. van Eden, D.J.A. Crommelin, and M.H.M. Wauben Targeting of Antibiotics to Bacterial Infections Using Long-Circulating Liposomes, R.M. Schiffelers, G. Storm, and I.A.J.M. Bakker-Woudenberg Optimal Delivery of Desferrioxamine (DFO) in the Treatment of Murine Malaria, N.S. Postma, C.C. Hermsen, W.M.C. Eling, O. Boerman, and J. Zuidema Poly ((2-dimethylamio) ethy methacrylate) Nanoparticles for Gene Transfection, H. Talsma, J.Y. Cherng, P.v.d. Wetering, D.J.A. Crommelin, and W.E. Hennink Liposomal Delivery of Cytokines for Anticancer Vaccination, M.L. van Slooten, F.J. Koppenhagen, J.J. Bergers, R. Kircheis, D.J.A. Crommelin, E. Wagner, and G. Storm Index